FiercePharma

Biogen Idec Receives Approval in the European Union for AVONEX® PEN™

European Commission approves the first single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX (interferon beta-1a) administration “At Biogen Idec, our commitment ...
Monthly Prescribing Reference

Avonex Pen and New Dose Titration Regimen Available

AVONEX PEN (interferon beta-1a) 30mcg/0.5mL solution for injection by Biogen Idec The Avonex Pen (interferon beta-1a 30mcg/0.5mL solution for injection), the first IM autoinjector for chronic use in ...
The Business Journals

Biogen Avonex Pen approved in EU

Biogen Idec has won European regulatory approval for a new delivery method for its blockbuster multiple sclerosis (MS) drug, Avonex, called the Avonex Pen. This is the first approval for the Avonex ...
FierceBiotech

Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN

-- First single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX recommended for approval in the European Union and authorised in Canada -- AVONEX PEN is designed ...
Business Wire

AVONEX PEN Now Available for Multiple Sclerosis Patients in Canada

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Biogen Idec Canada Inc today announced AVONEX ® PEN ™ is now available for patients with relapsing multiple sclerosis (MS) and patients with a single ...
elEconomista

FDA Approves AVONEX® PEN TM and Dose Titration Regimen

AVONEX PEN, the first intramuscular (IM) autoinjector approved for MS, incorporates a smaller needle and easier administration to help patients reduce anxiety about AVONEX self-injection. A new dose ...
GEN

EU Approves Biogen Idec’s Avonex Intramuscular Autoinjector Product for MS

Study showed 94% of patients preferred new device over existing Avonex prefilled syringe. The European regulatory authorities approved Biogen Idec’s single-use intramuscular autoinjector, Avonex PEN, ...
Drug Store News

FDA approves Biogen Idec's Avonex Pen, dose titration regimen

WESTON, Mass. — The Food and Drug Administration has approved two separate dosing innovations for multiple sclerosis patients that are being treated with a Biogen Idec drug. Biogen Idec said the FDA ...
The Business Journals

Biogen’s 'Avonex Pen' wins tentative EU nod

Biogen Idec (Nasdaq: BIIB), a biotechnology company best known for its blockbuster multiple sclerosis treatments, has announced that a European regulatory panel has given a positive recommendation to ...
FiercePharma

Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN

-- First single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX recommended for approval in the European Union and authorised in Canada -- AVONEX PEN is designed ...
Business Wire

CORRECTING and REPLACING Biogen Idec Receives Approval in the European Union for AVONEX ® PEN

ZUG, Switzerland--(BUSINESS WIRE)--Third paragraph, first sentence should read: ....AVONEX 30mcg/0.5ml... (sted ...AVONEX 30mcg/50ml...) The corrected release reads ...